Bloomberg News is reporting that U.S.
clinical research
“Bioethicists and IRBs typically ethically recoil from offering an incentivizing compensation for research participation, potentially unduly influencing vulnerable individuals/communities.”
A final “rule” regarding ClinicalTrials.gov was promulgated in 2017.
One of the significant problems for physicians is in translating research and guidelines into the care of their patients.